pone.0298914.s006.docx (32.42 kB)
Self-reported adverse events in adolescents while taking tenofovir disoproxil fumarate-emtricitabine for pre-exposure prophylaxis.
journal contribution
posted on 2024-02-22, 18:30 authored by Supattra Rungmaitree, Peerawong Werarak, Wadchara Pumpradit, Wanatpreeya Phongsamart, Keswadee Lapphra, Orasri Wittawatmongkol, Yuitiang Durier, Alan Maleesatharn, Beena Kuttiparambil, Tim R. Cressey, Risa M. Hoffman, Kulkanya ChokephaibulkitSelf-reported adverse events in adolescents while taking tenofovir disoproxil fumarate-emtricitabine for pre-exposure prophylaxis.
History
Usage metrics
Categories
Keywords
sexually transmitted infectionrisk thai adolescentsreported risk behaviouroffered daily tenofovirintracellular tenofovir diphosphateincreased risk compensationdecreased condom useadjusted odds ratio61 enrolled adolescentsurine molecular testingbone density scan027 ), presenceold without hivmedian age 18aor ]: 538 – 206 – 18115 – 584 – 56dp levels consistenthiv testingbone toxicity016 ),hiv prexlink ">weeks 12trachomatis pilot programone thirdmajor challengefactors associatedexposure prophylaxisc antiretroviral preacting modalities59 %)4 %)3 %.023 ).
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC